LabCompass

Raj Vuppalanchi

Medicine · Indiana University

Publications

359

Citations

15,890

Est. group size

Recurring co-author estimate

Active years

23

Publishing since 2004

Research summary
AI-generated

Raj Vuppalanchi studies liver diseases, focusing on fatty liver disease (now called MASLD/MASH, related to metabolic dysfunction), bile-duct disorders such as primary sclerosing cholangitis, and liver injury caused by drugs and vaccines. Much of the work involves clinical trials testing new medications and imaging methods (such as MRI-based measurements) to diagnose and track liver disease and its outcomes. The research combines drug testing, imaging biomarkers, and genetic factors linked to liver injury.

Fatty liver disease (MASLD/MASH)Clinical drug trials for liver diseaseDrug-induced liver injury and geneticsBile-duct disorders (cholangitis)Liver imaging biomarkers (MRI)

Publication activity has been steady and high across the last decade, generally ranging from about 17 to over 30 papers per year.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 19.2/year recently
2017: 12 publications172018: 26 publications182019: 18 publications192020: 32 publications32202021: 17 publications212022: 19 publications222023: 20 publications232024: 31 publications242025: 23 publications252026: 3 publications26
Recent publications
Publishes in
  • Gastroenterology×26
  • Journal of Hepatology×25
  • The American Journal of Gastroenterology×19
  • Alimentary Pharmacology & Therapeutics×15
  • Clinical Gastroenterology and Hepatology×13

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile